Last reviewed · How we verify

Edaravone Dexborneol — Competitive Intelligence Brief

Edaravone Dexborneol (Edaravone Dexborneol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Free radical scavenger combination. Area: Neurology.

marketed Free radical scavenger combination Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Edaravone Dexborneol (Edaravone Dexborneol) — First Affiliated Hospital, Sun Yat-Sen University. Edaravone Dexborneol is a combination of a free radical scavenger and a borneol-based neuroprotective agent that reduces oxidative stress and improves cerebral blood flow.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Edaravone Dexborneol TARGET Edaravone Dexborneol First Affiliated Hospital, Sun Yat-Sen University marketed Free radical scavenger combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Free radical scavenger combination class)

  1. First Affiliated Hospital, Sun Yat-Sen University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Edaravone Dexborneol — Competitive Intelligence Brief. https://druglandscape.com/ci/edaravone-dexborneol. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: